Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer
- PMID: 683276
- DOI: 10.1056/NEJM197808312990904
Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer
Abstract
We examined the relation of carcinoembryonic antigen levels to time, site and extent of recurrence in 358 patients with colorectal cancer. The recurrence rate was higher in patients with Dukes' B and Dukes' C lesions who had preoperative levels higher than 5 ng per milliliter. There was a linear inverse correlation between preoperative levels and estimated mean time to recurrence in patients with Dukes' B and C lesions, ranging from 30 months for a level of 2 to 9.8 months for a level of 70 ng per milliliter. In patients with Dukes' C lesions the median time to recurrence was 13 months if preoperative levels were higher than 5 ng per milliliter, and 28 months if they were lower. Preoperative carcinoembryonic antigen levels in patients with resectable Dukes' B and C cancer provided an additional criterion for allocating these patients to groups at high or low risk for recurrence.
Similar articles
-
Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.Anticancer Res. 2000 Nov-Dec;20(6D):5195-8. Anticancer Res. 2000. PMID: 11326694
-
Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.Anticancer Res. 1997 Jul-Aug;17(4B):2935-8. Anticancer Res. 1997. PMID: 9329568
-
The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer.Cancer. 1986 Aug 1;58(3):603-10. doi: 10.1002/1097-0142(19860801)58:3<603::aid-cncr2820580302>3.0.co;2-k. Cancer. 1986. PMID: 3731019
-
[Carcinoembryonic antigen, CEA, in colorectal cancer. An insensitive marker which may be excluded from follow-ups].Lakartidningen. 1997 Apr 30;94(18):1716-8. Lakartidningen. 1997. PMID: 9182180 Review. Swedish. No abstract available.
-
The use of carcinoembryonic antigen in the clinical management of colorectal cancer.Surg Clin North Am. 1979 Oct;59(5):831-9. doi: 10.1016/s0039-6109(16)41930-4. Surg Clin North Am. 1979. PMID: 390742 Review.
Cited by
-
Pre-operative evaluation of patients with low rectal carcinoma.World J Surg. 1992 May-Jun;16(3):430-6. doi: 10.1007/BF02104443. World J Surg. 1992. PMID: 1589977 Review.
-
Unrecognized Value of Carcinoembryonic Antigen in Recurrent Rectal and Sigmoid Colon Cancer: Case Series.Perm J. 2019;23:18-022. doi: 10.7812/TPP/18-022. Epub 2019 May 31. Perm J. 2019. PMID: 31167699 Free PMC article.
-
Association between carcinoembryonic antigen, carbohydrate antigen 19-9 and body mass index in colorectal cancer patients.Mol Clin Oncol. 2013 Sep;1(5):879-886. doi: 10.3892/mco.2013.158. Epub 2013 Jul 23. Mol Clin Oncol. 2013. PMID: 24649265 Free PMC article.
-
The clinicopathologic features of serum CA 19-9-positive colorectal cancers.Surg Today. 1994;24(6):518-25. doi: 10.1007/BF01884571. Surg Today. 1994. PMID: 7919734
-
Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer.Br J Cancer. 1996 Sep;74(6):925-9. doi: 10.1038/bjc.1996.458. Br J Cancer. 1996. PMID: 8826859 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources